vs

Side-by-side financial comparison of Dexcom (DXCM) and Primerica, Inc. (PRI). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $853.7M, roughly 1.5× Primerica, Inc.). Primerica, Inc. runs the higher net margin — 23.1% vs 21.2%, a 1.9% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 11.0%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 7.2%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Primerica, Inc. is a multi-level marketing company that provides insurance, investment and financial services to middle-income families in the United States and Canada.

DXCM vs PRI — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.5× larger
DXCM
$1.3B
$853.7M
PRI
Growing faster (revenue YoY)
DXCM
DXCM
+10.5% gap
DXCM
21.6%
11.0%
PRI
Higher net margin
PRI
PRI
1.9% more per $
PRI
23.1%
21.2%
DXCM
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
7.2%
PRI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DXCM
DXCM
PRI
PRI
Revenue
$1.3B
$853.7M
Net Profit
$267.3M
$197.0M
Gross Margin
62.9%
Operating Margin
25.6%
28.9%
Net Margin
21.2%
23.1%
Revenue YoY
21.6%
11.0%
Net Profit YoY
153.6%
17.9%
EPS (diluted)
$0.67
$6.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
PRI
PRI
Q1 26
$1.3B
Q4 25
$1.3B
$853.7M
Q3 25
$1.2B
$839.9M
Q2 25
$1.2B
$793.3M
Q1 25
$1.0B
$804.8M
Q4 24
$1.1B
$768.8M
Q3 24
$994.2M
$774.1M
Q2 24
$1.0B
$803.4M
Net Profit
DXCM
DXCM
PRI
PRI
Q1 26
$267.3M
Q4 25
$267.3M
$197.0M
Q3 25
$283.8M
$206.8M
Q2 25
$179.8M
$178.3M
Q1 25
$105.4M
$169.1M
Q4 24
$151.7M
$167.1M
Q3 24
$134.6M
$164.4M
Q2 24
$143.5M
$1.2M
Gross Margin
DXCM
DXCM
PRI
PRI
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
98.0%
Operating Margin
DXCM
DXCM
PRI
PRI
Q1 26
25.6%
Q4 25
25.6%
28.9%
Q3 25
20.1%
32.3%
Q2 25
18.4%
29.6%
Q1 25
12.9%
27.5%
Q4 24
17.0%
64.7%
Q3 24
15.3%
32.9%
Q2 24
15.7%
1.0%
Net Margin
DXCM
DXCM
PRI
PRI
Q1 26
21.2%
Q4 25
21.2%
23.1%
Q3 25
23.5%
24.6%
Q2 25
15.5%
22.5%
Q1 25
10.2%
21.0%
Q4 24
13.6%
21.7%
Q3 24
13.5%
21.2%
Q2 24
14.3%
0.1%
EPS (diluted)
DXCM
DXCM
PRI
PRI
Q1 26
$0.67
Q4 25
$0.67
$6.11
Q3 25
$0.70
$6.35
Q2 25
$0.45
$5.40
Q1 25
$0.27
$5.05
Q4 24
$0.37
$4.92
Q3 24
$0.34
$4.83
Q2 24
$0.35
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
PRI
PRI
Cash + ST InvestmentsLiquidity on hand
$917.7M
$756.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$2.4B
Total Assets
$6.3B
$15.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
PRI
PRI
Q1 26
$917.7M
Q4 25
$917.7M
$756.2M
Q3 25
$1.8B
$644.9M
Q2 25
$1.2B
$621.2M
Q1 25
$904.9M
$625.1M
Q4 24
$606.1M
$687.8M
Q3 24
$621.2M
$550.1M
Q2 24
$939.2M
$627.3M
Stockholders' Equity
DXCM
DXCM
PRI
PRI
Q1 26
$2.7B
Q4 25
$2.7B
$2.4B
Q3 25
$2.7B
$2.3B
Q2 25
$2.6B
$2.3B
Q1 25
$2.3B
$2.3B
Q4 24
$2.1B
$2.3B
Q3 24
$2.0B
$1.9B
Q2 24
$2.4B
$2.1B
Total Assets
DXCM
DXCM
PRI
PRI
Q1 26
$6.3B
Q4 25
$6.3B
$15.0B
Q3 25
$7.5B
$14.8B
Q2 25
$7.3B
$14.8B
Q1 25
$6.8B
$14.6B
Q4 24
$6.5B
$14.6B
Q3 24
$6.4B
$14.8B
Q2 24
$6.8B
$14.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
PRI
PRI
Operating Cash FlowLast quarter
$338.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.72×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
PRI
PRI
Q1 26
Q4 25
$294.0M
$338.2M
Q3 25
$659.9M
$202.9M
Q2 25
$303.0M
$162.6M
Q1 25
$183.8M
$197.5M
Q4 24
$301.4M
$270.6M
Q3 24
$199.5M
$207.3M
Q2 24
$279.4M
$173.3M
Free Cash Flow
DXCM
DXCM
PRI
PRI
Q1 26
Q4 25
$192.1M
Q3 25
$579.4M
Q2 25
$208.9M
Q1 25
$96.8M
Q4 24
$176.8M
Q3 24
$88.3M
Q2 24
$213.3M
FCF Margin
DXCM
DXCM
PRI
PRI
Q1 26
Q4 25
15.3%
Q3 25
47.9%
Q2 25
18.1%
Q1 25
9.3%
Q4 24
15.9%
Q3 24
8.9%
Q2 24
21.2%
Capex Intensity
DXCM
DXCM
PRI
PRI
Q1 26
Q4 25
8.1%
Q3 25
6.7%
Q2 25
8.1%
Q1 25
8.4%
Q4 24
11.2%
Q3 24
11.2%
Q2 24
6.6%
Cash Conversion
DXCM
DXCM
PRI
PRI
Q1 26
Q4 25
1.10×
1.72×
Q3 25
2.33×
0.98×
Q2 25
1.69×
0.91×
Q1 25
1.74×
1.17×
Q4 24
1.99×
1.62×
Q3 24
1.48×
1.26×
Q2 24
1.95×
147.98×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

PRI
PRI

Revenues From Sources Other Than Contracts With Customers$445.9M52%
Investment And Savings Products Segment Revenues$340.3M40%
Other$56.5M7%
Segment Revenues From Contracts With Customers$11.0M1%

Related Comparisons